# Hawthorn Bancshares, Inc.: financial statements, quarterly

HWBK · Nasdaq · CIK 893847 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/hwbk.md) · [Financials](/companies/hwbk/financials.md) · [Filings](/companies/hwbk/filings.md) · [Insiders](/companies/hwbk/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/hwbk/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Interest expense | $k | [8,741](/filings/0000893847-23-000023.md) | [9,375 d](/filings/0000893847-24-000002.md) | [9,304](/filings/0000893847-24-000011.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $k | [498](/filings/0000893847-24-000020.md) | [(2,262) d](/filings/0000893847-26-000037.md) | [966](/filings/0000893847-25-000015.md) | [1,033](/filings/0000893847-25-000036.md) | [1,050](/filings/0000893847-25-000042.md) | [1,053 d](/filings/0000893847-26-000037.md) | [1,213](/filings/0000893847-26-000063.md) | [1,367](/filings/0000893847-26-000088.md) | [1,358](/filings/0000893847-25-000042.md) | [1,360 d](/filings/0000893847-26-000037.md) | [1,389](/filings/0000893847-26-000063.md) | [1,604](/filings/0000893847-26-000088.md) |
| Net income | $k | [2,579](/filings/0000893847-24-000020.md) | [(7,443) d](/filings/0000893847-26-000037.md) | [4,456](/filings/0000893847-25-000015.md) | [4,629](/filings/0000893847-25-000036.md) | [4,574](/filings/0000893847-25-000042.md) | [4,597 d](/filings/0000893847-26-000037.md) | [5,383](/filings/0000893847-26-000063.md) | [6,101](/filings/0000893847-26-000088.md) | [6,132](/filings/0000893847-25-000042.md) | [6,185 d](/filings/0000893847-26-000037.md) | [5,743](/filings/0000893847-26-000063.md) | [7,326](/filings/0000893847-26-000088.md) |
| Diluted EPS | $ per share | [0.36](/filings/0000893847-24-000020.md) | not reported | [0.63](/filings/0000893847-25-000015.md) | [0.66](/filings/0000893847-25-000036.md) | [0.66](/filings/0000893847-25-000042.md) | not reported | [0.77](/filings/0000893847-26-000063.md) | [0.88](/filings/0000893847-26-000088.md) | [0.88](/filings/0000893847-25-000042.md) | not reported | [0.83](/filings/0000893847-26-000063.md) | [1.06](/filings/0000893847-26-000088.md) |
| Basic EPS | $ per share | [0.36](/filings/0000893847-24-000020.md) | not reported | [0.63](/filings/0000893847-25-000015.md) | [0.66](/filings/0000893847-25-000036.md) | [0.66](/filings/0000893847-25-000042.md) | not reported | [0.77](/filings/0000893847-26-000063.md) | [0.88](/filings/0000893847-26-000088.md) | [0.89](/filings/0000893847-25-000042.md) | not reported | [0.83](/filings/0000893847-26-000063.md) | [1.06](/filings/0000893847-26-000088.md) |

- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [27.9](/filings/0000893847-23-000023.md) | [93.5](/filings/0000893847-25-000002.md) | [43.5](/filings/0000893847-24-000011.md) | [75.8](/filings/0000893847-24-000016.md) | [54.2](/filings/0000893847-24-000020.md) | [51.0](/filings/0000893847-26-000037.md) | [102](/filings/0000893847-25-000015.md) | [100](/filings/0000893847-25-000036.md) | [99.9](/filings/0000893847-25-000042.md) | [104](/filings/0000893847-26-000088.md) | [102](/filings/0000893847-26-000063.md) | [32.7](/filings/0000893847-26-000088.md) |
| Total assets | $m | [1,879](/filings/0000893847-23-000023.md) | [1,875](/filings/0000893847-25-000002.md) | [1,834](/filings/0000893847-24-000011.md) | [1,848](/filings/0000893847-24-000016.md) | [1,810](/filings/0000893847-24-000020.md) | [1,825](/filings/0000893847-26-000037.md) | [1,883](/filings/0000893847-25-000015.md) | [1,877](/filings/0000893847-25-000036.md) | [1,932](/filings/0000893847-25-000042.md) | [1,895](/filings/0000893847-26-000088.md) | [1,856](/filings/0000893847-26-000063.md) | [1,773](/filings/0000893847-26-000088.md) |
| Total liabilities | $m | [1,761](/filings/0000893847-23-000023.md) | [1,739](/filings/0000893847-25-000002.md) | [1,697](/filings/0000893847-24-000011.md) | [1,710](/filings/0000893847-24-000016.md) | [1,663](/filings/0000893847-24-000020.md) | [1,676](/filings/0000893847-26-000037.md) | [1,730](/filings/0000893847-25-000015.md) | [1,721](/filings/0000893847-25-000036.md) | [1,767](/filings/0000893847-25-000042.md) | [1,721](/filings/0000893847-26-000088.md) | [1,680](/filings/0000893847-26-000063.md) | [1,590](/filings/0000893847-26-000088.md) |
| Short-term borrowings | $m | [6.2](/filings/0000893847-23-000023.md) | [0.0](/filings/0000893847-24-000002.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [118](/filings/0000893847-24-000020.md) | [136](/filings/0000893847-26-000037.md) | [137](/filings/0000893847-25-000036.md) | [138](/filings/0000893847-25-000042.md) | [146](/filings/0000893847-25-000042.md) | [150](/filings/0000893847-26-000088.md) | [153](/filings/0000893847-26-000088.md) | [157](/filings/0000893847-26-000088.md) | [165](/filings/0000893847-25-000042.md) | [174](/filings/0000893847-26-000088.md) | [175](/filings/0000893847-26-000088.md) | [183](/filings/0000893847-26-000088.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [4.5 d](/filings/0000893847-24-000020.md) | [5.3 d](/filings/0000893847-26-000037.md) | [5.6](/filings/0000893847-25-000015.md) | [8.9 d](/filings/0000893847-25-000036.md) | [9.1 d](/filings/0000893847-25-000042.md) | [1.9 d](/filings/0000893847-26-000037.md) | [5.7](/filings/0000893847-26-000063.md) | [5.8 d](/filings/0000893847-26-000088.md) | [0.3 d](/filings/0000893847-25-000042.md) | [15.1 d](/filings/0000893847-26-000037.md) | [8.0](/filings/0000893847-26-000063.md) | [10.2 d](/filings/0000893847-26-000088.md) |
| Capital expenditure | $m | [0.5 d](/filings/0000893847-24-000020.md) | [0.7 d](/filings/0000893847-26-000037.md) | [0.5](/filings/0000893847-25-000015.md) | [0.5 d](/filings/0000893847-25-000036.md) | [1.0 d](/filings/0000893847-25-000042.md) | [0.9 d](/filings/0000893847-26-000037.md) | [0.3](/filings/0000893847-26-000063.md) | [0.7 d](/filings/0000893847-26-000088.md) | [1.0 d](/filings/0000893847-25-000042.md) | [2.1 d](/filings/0000893847-26-000037.md) | [1.9](/filings/0000893847-26-000063.md) | [0.6 d](/filings/0000893847-26-000088.md) |
| Dividends paid | $m | [1.2 d](/filings/0000893847-24-000020.md) | [1.2 d](/filings/0000893847-26-000037.md) | [1.2](/filings/0000893847-25-000015.md) | [1.2 d](/filings/0000893847-25-000036.md) | [1.3 d](/filings/0000893847-25-000042.md) | [1.3 d](/filings/0000893847-26-000037.md) | [1.3](/filings/0000893847-26-000063.md) | [1.3 d](/filings/0000893847-26-000088.md) | [1.4 d](/filings/0000893847-25-000042.md) | [1.4 d](/filings/0000893847-26-000037.md) | [1.4](/filings/0000893847-26-000063.md) | [1.4 d](/filings/0000893847-26-000088.md) |
| Share repurchases | $m | [0.0 d](/filings/0000893847-24-000020.md) | [0.0 d](/filings/0000893847-26-000037.md) | [0.4](/filings/0000893847-25-000015.md) | [0.6 d](/filings/0000893847-25-000036.md) | [0.1 d](/filings/0000893847-25-000042.md) | [0.0 d](/filings/0000893847-26-000037.md) | [0.4](/filings/0000893847-26-000063.md) | [1.8 d](/filings/0000893847-26-000088.md) | [0.3 d](/filings/0000893847-25-000042.md) | [0.3 d](/filings/0000893847-26-000037.md) | [0.4](/filings/0000893847-26-000063.md) | [(0.0) d](/filings/0000893847-26-000088.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | thousands of shares | [7,039](/filings/0000893847-23-000023.md) | [7,039](/filings/0000893847-24-000011.md) | [7,039](/filings/0000893847-24-000016.md) | [7,039](/filings/0000893847-24-000020.md) | [7,032](/filings/0000893847-25-000015.md) | [6,996](/filings/0000893847-25-000036.md) | [6,987](/filings/0000893847-25-000042.md) | [6,998](/filings/0000893847-26-000063.md) | [6,945](/filings/0000893847-26-000088.md) | [6,922](/filings/0000893847-25-000042.md) | [6,914](/filings/0000893847-26-000063.md) | [6,906](/filings/0000893847-26-000088.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 6,900,678 at 2026-08-06, from the cover of the [10-Q filed 2026-08-06](/filings/0000893847-26-000088.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:27 ET. No prices; not investment advice.